Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke Within 4.5 h: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

<h3>Background</h3><p dir="ltr">Acute ischemic stroke (AIS) requires timely thrombolysis to restore perfusion and minimize neurological damage. Recombinant human prourokinase (rhPro‐UK) has emerged as a promising alternative to alteplase, with potential efficacy and safet...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Muhammad Hassan Waseem (22392178) (author)
مؤلفون آخرون:	Zain Ul Abideen (1410154) (author), Aiman Waheed (22392181) (author), Hafsa Arshad Azam Raja (20151441) (author), Sanan Rasheed (22392184) (author), Muhammad Mukhlis (22392187) (author), Muhammad Abdullah Ali (21409807) (author), Marium Khan (5125439) (author), Umama Alam (21761273) (author), Muhammad Fawad Tahir (22073279) (author), Javed Iqbal (2121922) (author), Ubaid Farooq (22392190) (author), Sania Aimen (22392193) (author)
منشور في:	2025
الموضوعات:	Biomedical and clinical sciences Cardiovascular medicine and haematology Neurosciences alteplase ischemic stroke meta-analysis recombinant human prourokinase systematic review
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke Within 4.5 h: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

مواد مشابهة